Efficacy of Co-enzyme Q-10 (Ubiquinone) in geriatrics community-acquired pneumonia

Trial Profile

Efficacy of Co-enzyme Q-10 (Ubiquinone) in geriatrics community-acquired pneumonia

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Ubidecarenone (Primary) ; Azithromycin; Ceftriaxone
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2014 Status changed from recruiting to active, no longer recruiting as per Iranian Registry of Clinical Trials record.
    • 20 Jan 2014 Recruitment was completed on 15 November 2013 as per Iranian Registry of Clinical Trials record.
    • 16 Aug 2013 Recruitment expected to complete on 15 November 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top